Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dinah Clark is active.

Publication


Featured researches published by Dinah Clark.


Nature | 2012

HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle.

Matthew A. Deardorff; Masashige Bando; Ryuichiro Nakato; Erwan Watrin; Takehiko Itoh; Masashi Minamino; Katsuya Saitoh; Makiko Komata; Yuki Katou; Dinah Clark; Kathryn E. Cole; Elfride De Baere; Christophe Decroos; Nataliya Di Donato; Sarah Ernst; Lauren J. Francey; Yolanda Gyftodimou; Kyotaro Hirashima; Melanie Hullings; Yuuichi Ishikawa; Christian Jaulin; Maninder Kaur; Tohru Kiyono; Patrick M. Lombardi; Laura Magnaghi-Jaulin; Geert Mortier; Naohito Nozaki; Michael B. Petersen; Hiroyuki Seimiya; Victoria M. Siu

Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesin-loading protein NIPBL for nearly 60% of individuals with classical CdLS, and by mutations in the core cohesin components SMC1A (∼5%) and SMC3 (<1%) for a smaller fraction of probands. In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein. These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion and also has key roles in gene regulation. SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin, and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase. Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands. Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissolution of the ‘used’ cohesin complex released from chromatin in both prophase and anaphase. SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunoprecipitation sequencing analysis demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.


PLOS Biology | 2009

Transcriptional Dysregulation in NIPBL and Cohesin Mutant Human Cells

Jinglan Liu; Zhe Zhang; Masashige Bando; Takehiko Itoh; Matthew A. Deardorff; Dinah Clark; Maninder Kaur; Stephany Tandy; Tatsuro Kondoh; Eric Rappaport; Nancy B. Spinner; Hugo Vega; Laird G. Jackson; Katsuhiko Shirahige; Ian D. Krantz

Genome-wide studies using cells from patients with Cornelia de Lange Syndrome reveal a role for cohesin in regulating gene expression in human cells.


Human Molecular Genetics | 2014

Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance

Frank J. Kaiser; Morad Ansari; Diana Braunholz; María Concepción Gil-Rodríguez; Christophe Decroos; Jonathan Wilde; Christopher T. Fincher; Maninder Kaur; Masashige Bando; David J. Amor; Paldeep Singh Atwal; Melanie Bahlo; Christine M. Bowman; Jacquelyn J. Bradley; Han G. Brunner; Dinah Clark; Miguel del Campo; Nataliya Di Donato; Peter Diakumis; Holly Dubbs; David A. Dyment; Juliane Eckhold; Sarah Ernst; Jose Carlos Ferreira; Lauren J. Francey; Ulrike Gehlken; Encarna Guillén-Navarro; Yolanda Gyftodimou; Bryan D. Hall; Raoul C. M. Hennekam

Cornelia de Lange syndrome (CdLS) is a multisystem genetic disorder with distinct facies, growth failure, intellectual disability, distal limb anomalies, gastrointestinal and neurological disease. Mutations in NIPBL, encoding a cohesin regulatory protein, account for >80% of cases with typical facies. Mutations in the core cohesin complex proteins, encoded by the SMC1A, SMC3 and RAD21 genes, together account for ∼5% of subjects, often with atypical CdLS features. Recently, we identified mutations in the X-linked gene HDAC8 as the cause of a small number of CdLS cases. Here, we report a cohort of 38 individuals with an emerging spectrum of features caused by HDAC8 mutations. For several individuals, the diagnosis of CdLS was not considered prior to genomic testing. Most mutations identified are missense and de novo. Many cases are heterozygous females, each with marked skewing of X-inactivation in peripheral blood DNA. We also identified eight hemizygous males who are more severely affected. The craniofacial appearance caused by HDAC8 mutations overlaps that of typical CdLS but often displays delayed anterior fontanelle closure, ocular hypertelorism, hooding of the eyelids, a broader nose and dental anomalies, which may be useful discriminating features. HDAC8 encodes the lysine deacetylase for the cohesin subunit SMC3 and analysis of the functional consequences of the missense mutations indicates that all cause a loss of enzymatic function. These data demonstrate that loss-of-function mutations in HDAC8 cause a range of overlapping human developmental phenotypes, including a phenotypically distinct subgroup of CdLS.


American Journal of Medical Genetics Part A | 2010

Facial Diagnosis of Mild and Variant CdLS: Insights from a Dysmorphologist Survey

Sarika Rohatgi; Dinah Clark; Antonie D. Kline; Laird G. Jackson; Juan Pié; Victoria M. Siu; Feliciano J. Ramos; Ian D. Krantz; Matthew A. Deardorff

Cornelia de Lange syndrome (CdLS) is a dominant disorder with classic severe forms and milder atypical variants. Central to making the diagnosis is identification of diagnostic facial features. With the recognition that patients with SMC1A and SMC3 mutations have milder, atypical features, we surveyed 65 dysmorphologists using facial photographs from 32 CdLS patients with the goals of (1) Illustrating examples of milder patients with SMC1A mutations and (2) Obtaining objective data to determine which facial features were useful and misleading in making a diagnosis of CdLS. Clinicians were surveyed whether the patient had CdLS or another diagnosis, the certainty of response and the clinical features used to support each response. Using only facial photographs, an average of 24 cases (75%) were accurately diagnosed per clinician. Correct diagnoses were made in 90% of classic CdLS and 87% of non‐CdLS cases, however, only 54% of mild or variant CdLS were correctly diagnosed by respondents. We confirmed that CdLS is most accurately diagnosed in childhood and the diagnosis becomes increasingly difficult with age. This survey demonstrated that emphasis is placed on the eyebrows, nasal features, prominent upper lip and micrognathia. In addition, the presence of fuller, atypical eyebrows, a prominent nasal bridge and significant prognathism with age dissuaded survey takers from arriving at a diagnosis of CdLS in individuals with mild NIPBL and SMC1A mutations. This work underscores the difficulty in diagnosing patients with mild and variant CdLS and serves to objectively classify both useful and misleading features in the diagnosis of CdLS.


American Journal of Medical Genetics Part A | 2012

Genome-wide SNP Genotyping Identifies the Stereocilin (STRC) Gene as a Major Contributor to Pediatric Bilateral Sensorineural Hearing Impairment

Lauren J. Francey; Laura K. Conlin; Hanna E. Kadesch; Dinah Clark; Donna Berrodin; Yi Sun; Joe Glessner; Hakon Hakonarson; Chaim Jalas; Chaim Landau; Nancy B. Spinner; Margaret A. Kenna; Michal Sagi; Heidi L. Rehm; Ian D. Krantz

Hearing loss is the most prevalent sensory perception deficit in humans, affecting 1/500 newborns, can be syndromic or nonsyndromic and is genetically heterogeneous. Nearly 80% of inherited nonsyndromic bilateral sensorineural hearing loss (NBSNHI) is autosomal recessive. Although many causal genes have been identified, most are minor contributors, except for GJB2, which accounts for nearly 50% of all recessive cases of severe to profound congenital NBSNHI in some populations. More than 60% of children with a NBSNHI do not have an identifiable genetic cause. To identify genetic contributors, we genotyped 659 GJB2 mutation negative pediatric probands with NBSNHI and assayed for copy number variants (CNVs). After identifying 8 mild‐moderate NBSNHI probands with a Chr15q15.3 deletion encompassing the Stereocilin (STRC) gene amongst this cohort, sequencing of STRC was undertaken in these probands as well as 50 probands and 14 siblings with mild‐moderate NBSNHI and 40 probands with moderately severe‐profound NBSNHI who were GJB2 mutation negative. The existence of a STRC pseudogene that is 99.6% homologous to the STRC coding region has made the sequencing interpretation complicated. We identified 7/50 probands in the mild‐moderate cohort to have biallelic alterations in STRC, not including the 8 previously identified deletions. We also identified 2/40 probands to have biallelic alterations in the moderately severe‐profound NBSNHI cohort, notably no large deletions in combination with another variant were found in this cohort. The data suggest that STRC may be a common contributor to NBSNHI among GJB2 mutation negative probands, especially in those with mild to moderate hearing impairment.


Nature Genetics | 2015

Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin

Kosuke Izumi; Ryuichiro Nakato; Zhe Zhang; Andrew C. Edmondson; Sarah E. Noon; Matthew C. Dulik; Ramkakrishnan Rajagopalan; Charles P. Venditti; Karen W. Gripp; Joy Samanich; Elaine H. Zackai; Matthew A. Deardorff; Dinah Clark; Julian L. Allen; Dale Dorsett; Ziva Misulovin; Makiko Komata; Masashige Bando; Maninder Kaur; Yuki Katou; Katsuhiko Shirahige; Ian D. Krantz

Transcriptional elongation is critical for gene expression regulation during embryogenesis. The super elongation complex (SEC) governs this process by mobilizing paused RNA polymerase II (RNAP2). Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia). Transcriptome and chromatin immunoprecipitation sequencing (ChIP-seq) analyses demonstrated similar alterations of genome-wide binding of AFF4, cohesin and RNAP2 in CdLS and CHOPS syndrome. Direct molecular interaction of the SEC, cohesin and RNAP2 was demonstrated. These data support a common molecular pathogenesis for CHOPS syndrome and CdLS caused by disturbance of transcriptional elongation due to alterations in genome-wide binding of AFF4 and cohesin.


Human Mutation | 2009

SMC1A expression and mechanism of pathogenicity in probands with X-Linked Cornelia de Lange syndrome†

Jinglan Liu; Rachel Feldman; Zhe Zhang; Matthew A. Deardorff; Eden V. Haverfield; Maninder Kaur; Jennifer R. Li; Dinah Clark; Antonie D. Kline; Darrel Waggoner; Soma Das; Laird G. Jackson; Ian D. Krantz

Cornelia de Lange Syndrome (CdLS) is a dominantly inherited heterogeneous genetic disorder with multisystem abnormalities. Sixty percent of probands with CdLS have heterozygous mutations in the Nipped‐B‐like (NIPBL) gene, 5% have mutations in the SMC1A gene, and one proband was found to have a mutation in the SMC3 gene. Cohesin is a multisubunit complex consisting of a SMC1A and SMC3 heterodimer and two non‐SMC subunits. SMC1A is located on the human X chromosome and is reported to escape X inactivation. Twenty‐nine unrelated CdLS probands with 21 unique SMC1A mutations have been identified including seven males. All mutations identified to date are either missense or small deletions, with all presumably preserving the protein open reading frame. Both wild‐type and mutant alleles are expressed. Females quantitatively express twice the amount of SMC1A mRNA compared to males. The transcriptional profiling of 23 selected genes is different in SMC1A mutant probands, controls, and NIPBL mutant probands. These results suggest that mechanistically SMC1A‐related CdLS is not due to altered levels of the SMC1A transcript, but rather that the mutant proteins maintain a residual function in males and enact a dominant negative effect in females. Hum Mutat 30:1–8, 2009.


Human Mutation | 2009

SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and copy number variation.

Binita M. Kamath; Brian D. Thiel; Xiaowu Gai; Laura K. Conlin; Pedro S. Munoz; Joseph T. Glessner; Dinah Clark; Daniel M. Warthen; Tamim H. Shaikh; Ercan Mihci; David A. Piccoli; Struan F. A. Grant; Hakon Hakonarson; Ian D. Krantz; Nancy B. Spinner

The use of array technology to define chromosome deletions and duplications is bringing us closer to establishing a genotype/phenotype map of genomic copy number alterations. We studied 21 patients and five relatives with deletions of the short arm of chromosome 20 using the Illumina HumanHap550 SNP array to: 1) more accurately determine the deletion sizes; 2) identify and compare breakpoints; 3) establish genotype/phenotype correlations; and 4) investigate the use of the HumanHap550 platform for analysis of chromosome deletions. Deletions ranged from 95 kb to 14.62 Mb, and all of the breakpoints were unique. Eleven patients had deletions between 95 kb and 4 Mb and these individuals had normal development, with no anomalies outside of those associated with Alagille syndrome (AGS). The proximal and distal boundaries of these 11 deletions constitute a 5.4‐Mb region, and we propose that haploinsufficiency for only 1 of the 12 genes in this region causes phenotypic abnormalities. This defines the JAG1‐associated critical region, in which deletions do not confer findings other than those associated with AGS. The other 10 patients had deletions between 3.28 Mb and 14.62 Mb, which extended outside the critical region, and, notably, all of these patients had developmental delay. This group had other findings such as autism, scoliosis, and bifid uvula. We identified 47 additional polymorphic genome‐wide copy number variants (>20 SNPs), with 0 to 5 variants called per patient. Deletions of the short arm of chromosome 20 are associated with relatively mild and limited clinical anomalies. The use of SNP arrays provides accurate high‐resolution definition of genomic abnormalities. Hum Mutat 0,1–8, 2008.


American Journal of Medical Genetics Part A | 2011

Causes of Death and Autopsy Findings in a Large Study Cohort of Individuals with Cornelia de Lange Syndrome and Review of the Literature

Matthew A. Deardorff; Dinah Clark; Lynn Audette; Lynette Gillis; Antonie D. Kline; Linda M. Ernst; Kathleen M. Loomes; Ian D. Krantz; Laird G. Jackson

To identify causes of death (COD) in propositi with Cornelia de Lange syndrome (CdLS) at various ages, and to develop guidelines to improve management and avoid morbidity and mortality, we retrospectively reviewed a total of 426 propositi with confirmed clinical diagnoses of CdLS in our database who died in a 41‐year period between 1966 and 2007. Of these, 295 had an identifiable COD reported to us. Clinical, laboratory, and complete autopsy data were completed on 41, of which 38 were obtainable, an additional 19 had autopsies that only documented the COD, and 45 propositi had surgical, imaging, or terminal event clinical documentation of their COD. Proband ages ranged from fetuses (21–40 weeks gestation) to 61 years. A literature review was undertaken to identify all reported causes of death in CdLS individuals. In our cohort of 295 propositi with a known COD, respiratory causes including aspiration/reflux and pneumonias were the most common primary causes (31%), followed by gastrointestinal disease, including obstruction/volvulus (19%). Congenital anomalies accounted for 15% of deaths and included congenital diaphragmatic hernia and congenital heart defects. Acquired cardiac disease accounted for 3% of deaths. Neurological causes and accidents each accounted for 8%, sepsis for 4%, cancer for 2%, renal disease for 1.7%, and other causes, 9% of deaths. We also present 21 representative clinical cases for illustration. This comprehensive review has identified important etiologies contributing to the morbidity and mortality in this population that will provide for an improved understanding of clinical complications, and management for children and adults with CdLS.


Human Mutation | 2015

De novo heterozygous mutations in SMC3 cause a range of Cornelia de Lange syndrome-overlapping phenotypes.

María Concepción Gil-Rodríguez; Matthew A. Deardorff; Morad Ansari; Christopher A. Tan; Ilaria Parenti; Carolina Baquero-Montoya; Lilian Bomme Ousager; Beatriz Puisac; María Hernández-Marcos; María Esperanza Teresa-Rodrigo; Íñigo Marcos-Alcalde; Jan Jaap Wesselink; Silvia Lusa-Bernal; Emilia K. Bijlsma; Diana Braunholz; Inés Bueno-Martínez; Dinah Clark; Nicola S. Cooper; Cynthia J. Curry; Richard Fisher; Alan Fryer; Jaya Ganesh; Cristina Gervasini; Gabriele Gillessen-Kaesbach; Yiran Guo; Hakon Hakonarson; Robert J. Hopkin; Maninder Kaur; Brendan J. Keating; Maria Kibæk

Cornelia de Lange syndrome (CdLS) is characterized by facial dysmorphism, growth failure, intellectual disability, limb malformations, and multiple organ involvement. Mutations in five genes, encoding subunits of the cohesin complex (SMC1A, SMC3, RAD21) and its regulators (NIPBL, HDAC8), account for at least 70% of patients with CdLS or CdLS‐like phenotypes. To date, only the clinical features from a single CdLS patient with SMC3 mutation has been published. Here, we report the efforts of an international research and clinical collaboration to provide clinical comparison of 16 patients with CdLS‐like features caused by mutations in SMC3. Modeling of the mutation effects on protein structure suggests a dominant‐negative effect on the multimeric cohesin complex. When compared with typical CdLS, many SMC3‐associated phenotypes are also characterized by postnatal microcephaly but with a less distinctive craniofacial appearance, a milder prenatal growth retardation that worsens in childhood, few congenital heart defects, and an absence of limb deficiencies. While most mutations are unique, two unrelated affected individuals shared the same mutation but presented with different phenotypes. This work confirms that de novo SMC3 mutations account for ∼1%–2% of CdLS‐like phenotypes.

Collaboration


Dive into the Dinah Clark's collaboration.

Top Co-Authors

Avatar

Ian D. Krantz

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Matthew A. Deardorff

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Maninder Kaur

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Hakon Hakonarson

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Antonie D. Kline

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nancy B. Spinner

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laura K. Conlin

Children's Hospital of Philadelphia

View shared research outputs
Researchain Logo
Decentralizing Knowledge